POST Online Media Lite Edition


Aridis Pharmaceuticals appoints Hasan Jafri as chief medical officer

Christian Fernsby |
San Jose, Ca., USA - Aridis Pharmaceuticals, a biopharmaceutical company, announced that it has appointed Hasan Jafri as chief medical officer.

Dr. Jafri comes to Aridis from AstraZeneca, where he most recently served as Senior Medical Director, Clinical Research and Development, Microbial Sciences, Clinical Head of Antibacterial mAb Program, and Coordinator of the European Public Private Combacte Net And Combacte Magnet Consortia.

Dr. Jafri has over 25 years of experience in clinical practice and research.

Prior to joining AstraZeneca, Dr. Jafri served as a Professor in the Department of Pediatric Infectious Diseases and the Department of Clinical Science Research at the University of Texas Southwestern Medical Center at Dallas.

Dr. Jafri was the Chief of Division of Clinical Pharmacology, Director of the Pediatric Infectious Diseases fellowship program, and Director of the NICHD Pediatric Pharmacology Research Center.